Yıl: 2023 Cilt: 5 Sayı: 1 Sayfa Aralığı: 208 - 217 Metin Dili: İngilizce DOI: 10.5152/ABCR.2023.221323 İndeks Tarihi: 04-06-2023

Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry

Öz:
Objective: Autism spectrum disorder is defined by repetitive and restricted behaviors and lack of social interactions and commu- nication. It is described as a neurodevelopmental disorder that appears early in life. Autism spectrum disorder was later noted as multifactorial disorder caused by environment, genetic, and other related factors. Amino acids are the precursors of neu- rotransmitters, and they are involved in the pathogenesis of sev- eral diseases and have many functions and effects in the body. They are indicators of protein metabolism and nutritional status. Because of its important properties and its potential relation- ship with autism, this study aimed to investigate serum amino acid levels in 20 healthy children and 25 children with autism spectrum disorder. Methods: Serum amino acid levels were analyzed by liquid chro- matography-mass spectrometry/mass spectrometry. Results: Autism spectrum disorder group had a lower serum concentration of gamma-aminobutyric acid, aspartic acid, and beta-aminoisobutyric acid levels compared to the control group, while glutamic acid, tryptophan, alanine, glycine, proline, ornithine, histidine, and serotonin levels had statistically higher concentrations (P < .05). And also, serum levels of asparagine, arginine, methionine, serine, valine, tyrosine, threonine, lysine leucine, beta alanine, anserine, hydroxyproline, argininosucci- nate, isoleucine, sarcosine, citrulline, histamine, phenylalanine, and glutamine were not found to be statistically lower or higher (P > .05). Conclusion: The study indicated that when compared to the control group, children with autism spectrum disorder had sta- tistically significantly decreased and increased variation in some serum levels of amino acid.
Anahtar Kelime:

Otizm Spektrum Bozukluğu Olan Çocukların Serum Amino Asit Düzeylerinin LC-MS/MS Metoduyla Belirlenmesi

Öz:
Amaç: Otizm spektrum bozukluğu, tekrarlayıcı ve kısıtlı davranış- lar ve sosyal etkileşim ve iletişim eksikliği ile tanımlanır. Yaşamın erken dönemlerinde ortaya çıkan nörogelişimsel bir bozukluktur. Otizm spektrum bozukluğu daha sonra çevresel, genetik ve diğer ilgili faktörlerin neden olduğu çok faktörlü bir bozukluk olarak tanımlanmıştır. Amino asitler, nörotransmiterlerin öncüleridir ve birçok hastalığın patogenezinde yer alırlar ve vücutta birçok işlev ve etkiye sahiptirler. Protein metabolizmasının ve beslenme durumunun göstergeleridir. Önemli özellikleri ve otizm ile potan- siyel ilişkisi nedeniyle, otizm spektrum bozukluğu olan çocukla- rın serum amino asit düzeylerinin araştırılması amaçladı. Yöntemler: Bu çalışmaya 20 sağlıklı çocuk ve 25 otizim spekt- rum bozukluğu olan çocuk dahil edilmiştir. Serum amino asit seviyeleri, sıvı kromatografi-kütle spektrometrisi/kütle spektro- metrisi ile analiz edildi. Bulgular: Otizm spektrum bozukluğu grubunda gama-a- minobütirik asit, aspartik asit ve beta-aminoizobütirik asit düzeyleri kontrol grubuna göre daha düşükken, glutamik asit, triptofan, alanin, glisin, prolin, ornitin, histidin ve serotonin sevi- yeleri istatistiksel olarak daha yüksek konsantrasyonlara sahipti. (p < .05). Ayrıca asparagin, arjinin, metiyonin, serin, valin, tiro- zin, treonin, lizin, lösin, beta alanin, anserin, hidroksiprolin, argininosüksinat, izolösin, sarkozin, sitrülin, histamin, fenilalanin ve glutaminserumdüzeylerindeistatistikselolarakfarklılıkbulunmadı (P > ,05). Sonuç: Çalışma, sağlıklı kontrol grubu ile karşılaştırıldığında, otizm spektrum bozukluğu olan çocukların bazı serum amino asit düzeylerinin istatistiksel olarak anlamlı derecede azaldığını ve arttığını göstermiştir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910. [CrossRef]
  • 2. Young RL, Rodi ML. Redefining autism spectrum disorder using DSM-5: the implications of the proposed DSM-5 cri- teria for autism spectrum disorders. J Autism Dev Disord. 2014;44(4):758-765. [CrossRef]
  • 3. Lyall K, Croen L, Daniels J, et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81-102. [CrossRef]
  • 4. Lauritsen MB, Pedersen CB, Mortensen PB. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med. 2004;34(7): 1339-1346. [CrossRef]
  • 5. Dietert RR, Dietert JM, Dewitt JC. Environmental risk factors for autism. Emerg Health Threats J. 2011;4:7111. [CrossRef]
  • 6. Simmons DR, Robertson AE, McKay LS, Toal E, McAleer P, Pollick FE. Vision in autism spectrum disorders. Vision Res. 2009;49(22):2705-2739. [CrossRef]
  • 7. Walsh P, Elsabbagh M, Bolton P, Singh I. In search of bio- markers for autism: scientific, social and ethical challenges. Nat Rev Neurosci. 2011;12(10):603-612. [CrossRef]
  • 8. Żurawicz E, Kałużna-Czaplińska J. Analysis of amino acids in autism spectrum disorders. TrAC Trends Anal Chem. 2015;73:91-118. [CrossRef]
  • 9. Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypi- cal children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34. [CrossRef]
  • 10. Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB. Determination of D-serine and related neuroactive amino acids in human plasma by high-performance liquid chroma- tography with fluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;844(2):278-282. [CrossRef]
  • 11. Evans C, Dunstan RH, Rothkirch T, et al. Altered amino acid excretion in children with autism. Nutr Neurosci. 2008;11(1): 9-17. [CrossRef]
  • 12. Masi A, DeMayo MM, Glozier N, Guastella AJ. An overview of autism spectrum disorder, heterogeneity and treatment options. Neurosci Bull. 2017;33(2):183-193. [CrossRef]
  • 13. Subramanian M, Timmerman CK, Schwartz JL, Pham DL, Meffert MK. Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci. 2015;9:313. [CrossRef]
  • 14. Bugajska J, Berska J, Wojtyto T, Bik-Multanowski M, Sztefko K. The amino acid profile in blood plasma of young boys with autism. Psychiatr Pol. 2017;51(2):359-368. [CrossRef]
  • 15. Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34. [CrossRef]
  • 16. Shinohe A, Hashimoto K, Nakamura K, et al. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(8): 1472-1477. [CrossRef]
  • 17. Robertson CE, Ratai EM, Kanwisher N, Reduced GAB. Reduced GABAergic action in the autistic brain. Curr Biol. 2016;26(1):80-85. [CrossRef]
  • 18. El-Ansary A, Al-Ayadhi L. GABAe rgic/glutamatergic imbal- ance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation. 2014;11:189. [CrossRef]
  • 19. Dhossche D, Applegate H, Abraham A, et al. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic young- sters: stimulus for a GABA hypothesis of autism. Med Sci Monit. 2002;8(8):PR1-PR6.
  • 20. Shimmura C, Suda S, Tsuchiya KJ, et al. Alteration of plasma glutamate and glutamine levels in children with high-func- tioning autism. PLoS One. 2011;6(10):e25340. [CrossRef]
  • 21. Ghanizadeh A. Methionine sulfoximine may improve inflam- mation in autism, a novel hypothesized treatment for autism. Arch Med Res. 2010;41(8):651-652. [CrossRef]
  • 22. Ming X, Stein TP, Barnes V, Rhodes N, Guo L. Metabolic per- turbance in autism spectrum disorders: a metabolomics study. J Proteome Res. 2012;11(12):5856-5862. [CrossRef]
  • 23. Mavel S, Nadal-Desbarats L, Blasco H, et al. 1H-13C NMR- based urine metabolic profiling in autism spectrum disor- ders. Talanta. 2013;114:95-102. [CrossRef]
  • 24. Bala KA, Doğan M, Mutluer T, et al. Plasma amino acid profile in autism spectrum disorder (ASD). Eur Rev Med Pharmaco Sci. 2016;20(5):923-929.
  • 25. Tyzio R, Cossart R, Khalilov I, et al. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science. 2006;314(5806):1788-1792. [CrossRef]
  • 26. Tyzio R, Nardou R, Ferrari DC, et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism patho- genesis in rodent offspring. Science. 2014;343(6171): 675-679. [CrossRef]
  • 27. Zheng HF, Wang WQ, Li XM, Rauw G, Baker GB. Body fluid levels of neuroactive amino acids in autism spectrum dis- orders: a review of the literature. Amino Acids. 2017;49(1): 57-65. [CrossRef]
  • 28. Nadal-Desbarats L, Aïdoud N, Emond P, et al. Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders. Analyst. 2014; 139(13):3460-3468. [CrossRef]
  • 29. Naushad SM, Jain JM, Prasad CK, Naik U, Akella RR. Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys. 2013;50(5):474-478.
  • 30. D’Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O. Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmaco- ther. 1995;49(6):288-292. [CrossRef]
  • 31. Tirouvanziam R, Obukhanych TV, Laval J, et al. Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism Spectrum Disorders. J Autism Dev Disord. 2012;42(5):827-836. [CrossRef]
  • 32. ElBaz FM, Zaki MM, Youssef AM, ElDorry GF, Elalfy DY. Study of plasma amino acid levels in children with autism: an Egyptian sample. Egypt J Med Hum Genet. 2014;15(2): 181-186. [CrossRef]
  • 33. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil. 2006;27(3):254-289. [CrossRef]
  • 34. Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in autism spectrum disorder: from bio- marker to animal models. Neuroscience. 2016;321:24-41. [CrossRef]
  • 35. Tu WJ, Chen H, He J. Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Biochem Nutr. 2012;51(3):248-249. [CrossRef]
  • 36. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand. 1993;87(5):312-316. [CrossRef]
  • 37. Perry TL, Hansen S, Christie RG. Amino compounds and organic acids in CSF, plasma, and urine of autistic children. Biol Psychiatry. 1978;13(5):575-586.
  • 38. Evans C, Dunstan RH, Rothkirch T, et al. Altered amino acid excretion in children with autism. Nutr Neurosci. 2008; 11(1):9-17. [CrossRef]
  • 39. Wright C, Shin JH, Rajpurohit A, et al. Altered expression of histamine signaling genes in autism spectrum disorder. Transl Psychiatry. 2017;7(5):e1126. [CrossRef]
  • 40. Launay JM, Ferrari P, Haimart M, et al. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiol- ogy. 1988;20(1):1-11. [CrossRef]
APA Gül M, umudum f, KURT N, OZGERIS F, Türkeri Ö, Turan B, Dursun O, keles M (2023). Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. , 208 - 217. 10.5152/ABCR.2023.221323
Chicago Gül Mehmet Ali,umudum fatma zuhal,KURT Nezahat,OZGERIS FATMA BETÜL,Türkeri Özge Nur,Turan Bahadır,Dursun Onur Burak,keles Mevlut sait Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. (2023): 208 - 217. 10.5152/ABCR.2023.221323
MLA Gül Mehmet Ali,umudum fatma zuhal,KURT Nezahat,OZGERIS FATMA BETÜL,Türkeri Özge Nur,Turan Bahadır,Dursun Onur Burak,keles Mevlut sait Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. , 2023, ss.208 - 217. 10.5152/ABCR.2023.221323
AMA Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. . 2023; 208 - 217. 10.5152/ABCR.2023.221323
Vancouver Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. . 2023; 208 - 217. 10.5152/ABCR.2023.221323
IEEE Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M "Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry." , ss.208 - 217, 2023. 10.5152/ABCR.2023.221323
ISNAD Gül, Mehmet Ali vd. "Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry". (2023), 208-217. https://doi.org/10.5152/ABCR.2023.221323
APA Gül M, umudum f, KURT N, OZGERIS F, Türkeri Ö, Turan B, Dursun O, keles M (2023). Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. Archives of Basic and Clinical Research, 5(1), 208 - 217. 10.5152/ABCR.2023.221323
Chicago Gül Mehmet Ali,umudum fatma zuhal,KURT Nezahat,OZGERIS FATMA BETÜL,Türkeri Özge Nur,Turan Bahadır,Dursun Onur Burak,keles Mevlut sait Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. Archives of Basic and Clinical Research 5, no.1 (2023): 208 - 217. 10.5152/ABCR.2023.221323
MLA Gül Mehmet Ali,umudum fatma zuhal,KURT Nezahat,OZGERIS FATMA BETÜL,Türkeri Özge Nur,Turan Bahadır,Dursun Onur Burak,keles Mevlut sait Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. Archives of Basic and Clinical Research, vol.5, no.1, 2023, ss.208 - 217. 10.5152/ABCR.2023.221323
AMA Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. Archives of Basic and Clinical Research. 2023; 5(1): 208 - 217. 10.5152/ABCR.2023.221323
Vancouver Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry. Archives of Basic and Clinical Research. 2023; 5(1): 208 - 217. 10.5152/ABCR.2023.221323
IEEE Gül M,umudum f,KURT N,OZGERIS F,Türkeri Ö,Turan B,Dursun O,keles M "Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry." Archives of Basic and Clinical Research, 5, ss.208 - 217, 2023. 10.5152/ABCR.2023.221323
ISNAD Gül, Mehmet Ali vd. "Serum Amino Acid Levels in Children with Autism Spectrum Disorder by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry". Archives of Basic and Clinical Research 5/1 (2023), 208-217. https://doi.org/10.5152/ABCR.2023.221323